A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.

A front-of-package food label would be a great educational tool. The Trump administration should keep it.

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...

The way the world defines obesity has been in need of an overhaul, according to some experts, and it could be coming soon ...

For years, medical experts have defined obesity primarily based on body mass index, which measures stored fat by calculating ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION ... have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug, ...